1-8 of 8
Chengcheng Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Epigenetic agents plus anti-PD-1 reprogram the tumor microenvironment and restore antitumor efficacy in Hodgkin lymphoma

Clinical Trials & Observations
Jing Nie, Chunmeng Wang, Liangtao Zheng, Yang Liu, Chengcheng Wang, Yixin Chang, Yudi Hu, Bing Guo, Yuting Pan, Qingming Yang, Xueda Hu, Weidong Han
Journal: Blood
Blood (2024) 144 (18): 1936–1950.
https://doi.org/10.1182/blood.2024024487
Published: 2024
Includes: Supplemental data
Journal Articles

Validation of Circulating Tumor DNA As an Alternative to Tumor Tissue Biopsy in Genotyping across Multiple Lymphoma Subtypes

Haisheng Liu, Yue Yuan, Lili Wu, Lanping Diao, Yuhuan Gao, Chengcheng Wang, Pingping Zou, Shanbo Cao, Jiayue Qin
Journal: Blood
Blood (2023) 142 (Supplement 1): 4372.
https://doi.org/10.1182/blood-2023-180642
Published: 2023
Journal Articles

A Risk Score Combined Clinical and Molecular Profiles Identifies a High-Risk Subgroup within AML1-ETO-Positive Acute Myeloid Leukemia

Min Yang, MD PhD, Yi Zhang, MDcal Master, Jinghan Wang, MDPhD, Lixia Liu, Chengcheng Wang, Feng Lou, Shanbo Cao, Jie Jin, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19.
https://doi.org/10.1182/blood-2020-142100
Published: 2020
Journal Articles

Prognostic Prediction Clinical-Molecular Model for Allogeneic Transplant Outcomes in Patients with Myelodysplastic Syndrome

Zixian Liu, Erlie Jiang, Yi He, Lixia Liu, Chengcheng Wang, Jialin Wei, Donglin Yang, Tao Zhou, Aiming Pang, MD PhD, Yong Huang, Rongli Zhang, MD, Qiaoling Ma, Mengmeng Zhang, Feng Lou, Shanbo Cao, Qianqian Wang, Weihua Zhai, MD, Sizhou Feng, Zhijian Xiao, MD, Ming-Zhe Han, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-140676
Published: 2020
Journal Articles

Genomic Landscape and Risk-Stratification for De Novo Acute Myeloid Leukemia with Normal Cytogenetics and No NPM1 or FLT3- itd Mutation

Ya-Lan Zhou, MD, Li-Xin Wu, Robert Peter Gale, Zi-Long Wang, Jin-Lan Li, Hao Jiang, Qian Jiang, MD, Bin Jiang, Shan-Bo Cao, Feng Lou, Ying Sun, Chengcheng Wang, Ting Li, Yan-Rong Liu, Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Xiaohui Zhang, MD, Kaiyan Liu, Guorui Ruan, Xiaojun Huang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1421.
https://doi.org/10.1182/blood-2019-127937
Published: 2019
Journal Articles

Dead/H-Box Helicase 11 ( DDX11 ) Mutations Correlate with Increased Relapse Risk in Persons with Acute Myeloid Leukaemia and Promote Proliferation and Survival of Human AML Cells in Vitro and in Immune Deficient Mice

Ya-Lan Zhou, MD, Li-Xin Wu, Robert Peter Gale, Zi-Long Wang, Jin-Lan Li, Hao Jiang, Qian Jiang, MD, Bin Jiang, Shan-Bo Cao, Ying Sun, Feng Lou, Chengcheng Wang, Yan-Rong Liu, Yu Wang, Ying-Jun Chang, Lanping Xu, Xiaohui Zhang, MD, Kaiyan Liu, Guorui Ruan, Xiaojun Huang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2732.
https://doi.org/10.1182/blood-2019-127831
Published: 2019
Journal Articles

A Risk Score Combined Clinical and Molecular Profiles Identifies a High-Risk Subgroup within Intermediate-Risk Acute Myeloid Leukemia

Xiaoxia Hu, Aijie Huang, Qi Chen, Ying Zhang, Lixia Liu, Chengcheng Wang, Weiping Zhang, Jianmin Yang, Jianmin Wang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2713.
https://doi.org/10.1182/blood-2019-129186
Published: 2019
Journal Articles

Multidimensional Study on the Prognostic Factors of Acute Myeloid Leukemia Patients with FLT3-ITD mutations Based on the Next-Generation Sequencing Platform

Yi Zhang, MDcal Master, Bide Zhao, Yungui Wang, PhD, Dongmei Wang, Hanzhang Pan, Chengcheng Wang, Feng Lou, Shanbo Cao, Jie Jin, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5281.
https://doi.org/10.1182/blood-2018-99-116178
Published: 2018